Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (701-710 of 831) with videos related to

Pageof 84
Sort By:
Neuro-Oncology|November 21, 2019
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastomaMartin Van Den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial ExperiencesNorbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Neuro-Oncology|May 27, 2026
Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science IntegrationYolanda Piña, Maxine Umeh Garcia, Adrienne Boire, et al.
Neuro-Oncology Practice|May 14, 2026
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research projectEvangelia Razis, Thierry Gorlia, Matthias Preusser, et al.
International Journal of Cancer|March 12, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingGuido Reifenberger, Ruthild G Weber, Vera Riehmer, et al.
The Lancet. Oncology|October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translationAnahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.
Science Translational Medicine|June 18, 2025
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma modelsMiaomiao Sun, Maciej Bialasek, Maud Mayoux, et al.
Pageof 84

Showing results (701-710 of 831) with videos related to

Sort By:
Pageof 84
Neuro-Oncology|November 21, 2019
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastomaMartin Van Den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial ExperiencesNorbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Neuro-Oncology|May 27, 2026
Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science IntegrationYolanda Piña, Maxine Umeh Garcia, Adrienne Boire, et al.
Neuro-Oncology Practice|May 14, 2026
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research projectEvangelia Razis, Thierry Gorlia, Matthias Preusser, et al.
International Journal of Cancer|March 12, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingGuido Reifenberger, Ruthild G Weber, Vera Riehmer, et al.
The Lancet. Oncology|October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translationAnahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.
Science Translational Medicine|June 18, 2025
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma modelsMiaomiao Sun, Maciej Bialasek, Maud Mayoux, et al.
Pageof 84